Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(6%)
Results Posted
33%(1 trials)

Phase Distribution

Ph phase_3
1
6%
Ph not_applicable
1
6%
Ph phase_2
14
88%

Phase Distribution

0

Early Stage

14

Mid Stage

1

Late Stage

Phase Distribution16 total trials
Phase 2Efficacy & side effects
14(87.5%)
Phase 3Large-scale testing
1(6.3%)
N/ANon-phased studies
1(6.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

16

all time

Status Distribution
Active(3)
Completed(3)
Other(10)

Detailed Status

unknown10
Completed3
Not yet recruiting2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
16
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 214 (87.5%)
Phase 31 (6.3%)
N/A1 (6.3%)

Trials by Status

unknown1063%
active_not_recruiting16%
completed319%
not_yet_recruiting213%

Recent Activity

1 active trials
Showing 5 of 16
not_yet_recruitingnot_applicable

TBF Conditioning Regimen for Haploidentical Stem Cell Transplantation in Elderly AML Patients in First Complete Remission

NCT07563920
active_not_recruitingphase_2

Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy

NCT03674411
not_yet_recruitingphase_2

VEN+DAC+Bu2Flu4 vs Bu2Flu5 Conditioning Regimen for Elderly Myeloid Malignancies Undergoing Allo-HSCT

NCT07052422
unknownphase_2

G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for High-risk MDS Undergoing Allo-HSCT

NCT05453552
unknownphase_2

G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for Secondary Acute Myeloid Leukemia Undergoing Allo-HSCT

NCT05449899
View all 16 trials

Clinical Trials (16)

Showing 16 of 16 trials
NCT07563920Not Applicable

TBF Conditioning Regimen for Haploidentical Stem Cell Transplantation in Elderly AML Patients in First Complete Remission

Not Yet Recruiting
NCT03674411Phase 2

Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy

Active Not Recruiting
NCT07052422Phase 2

VEN+DAC+Bu2Flu4 vs Bu2Flu5 Conditioning Regimen for Elderly Myeloid Malignancies Undergoing Allo-HSCT

Not Yet Recruiting
NCT05453552Phase 2

G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for High-risk MDS Undergoing Allo-HSCT

Unknown
NCT05449899Phase 2

G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for Secondary Acute Myeloid Leukemia Undergoing Allo-HSCT

Unknown
NCT02670252Phase 3

BuCY vs TBICY Conditioning Regimen for Standard-risk ALL Undergoing Allo-HSCT

Completed
NCT02744742Phase 2

G-CSF+Decitabine+BUCY vs BUCY Conditioning Regimen for RAEB-1, REAB-2 and AML Secondary to MDS Undergoing Allo-HSCT

Completed
NCT04713956Phase 2

G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for RAEB-1,REAB-2 and AML Secondary to MDS Undergoing Allo-HSCT

Unknown
NCT03530085Phase 2

Dec+Flu+Bu Conditioning Regimen for Elderly AML in CR Undergoing Allo-HSCT

Unknown
NCT02671708Phase 2

IDA+BUCY vs BUCY Conditioning Regimen for Intermediate-risk AML Undergoing Auto-HSCT

Completed
NCT03385096Phase 2

Mel vs BUCY+VP-16 Conditioning Regimen for MM Undergoing Auto-HSCT

Unknown
NCT04123392Phase 2

Decitabine + BUCY vs BUCY Conditioning Regimen for TP53+ Myeloid Tumors Undergoing Allo-HSCT

Unknown
NCT04098653Phase 2

Decitabine + BUCY vs BUCY Conditioning Regimen for Myeloid Tumors Undergoing Allo-HSCT

Unknown
NCT03733327Phase 2

BUCYE Conditioning Regimen for PCNSL Undergoing Auto-HSCT

Unknown
NCT03596892Phase 2

Decitabine+BUCY vs BUCY Conditioning Regimen for MLL+ Acute Leukemia Undergoing Allo-HSCT

Unknown
NCT03229616Phase 2

BUCY+VP-16 vs BUCY Conditioning Regimen for DLBCL Undergoing Auto-HSCT

Unknown

All 16 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
16